Social Media Influencers Driving Parallel Market for Unapproved Weight-Loss Drug
An underground economy for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, based on new investigations.
Experimental Treatment Gaining Traction Via Social Media
Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these accounts privately for supplier links, while also receiving promotional offers.
Active Trade on Social Networks
Additionally, a robust market exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and claims of next-day UK delivery. Vendors promote the drug there before redirecting buyers to other platforms for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Experts Voice Concerns
Nevertheless, physicians and chemists have warned that the distribution of what remains an unapproved drug in the UK is worrisome and could lead to users injecting products of uncertain source.
Some experts stated the demand for the experimental drug could be connected to the increasing price of licensed slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the British medical regulations.
Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still breach pharmaceutical, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.
Service Reaction and Material Removal
Based on the social media company, the service has taken down problematic content and banned related keywords and search suggestions. The organization said it was committed to maintaining the platform safe and allocating resources in strengthening compliance measures.
Online Trading Operations
Research also found groups with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of members, filled with photos of weight loss, positive reviews and step-by-step instructions for preparing or administering at residence.
Within minutes of joining one community, a seller posted WhatsApp details, where most transactions occur. The seller provided an guidebook and promised shipping within 48 hours. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, health issues or past usage.
Item Information and Pricing
Inside these communities, posts display dark colored packages with Royal Mail stickers, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with sterile water, or pre-filled injectors usually priced at 160 pounds for 20 milligrams. When asked how much time a pen should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A representative for Telegram stated it actively moderated harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting materials they can’t verify. Even if the science behind this drug is sound, these digital products may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current cost increases for approved slimming medications such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.
Her team has already seen individuals injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company experimental substance not yet authorized … may expose users to possibly serious health risks”.